BRTX
NASDAQ · Biotechnology
Biorestorative Therapies Inc
$1.56
+0.03 (+1.96%)
Open$1.58
Previous Close$1.53
Day High$1.59
Day Low$1.51
52W High$29.80
52W Low$1.28
Volume—
Avg Volume42.9K
Market Cap2.10M
P/E Ratio—
EPS$-15.98
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,577.6% upside
Current
$1.56
$1.56
Target
$26.17
$26.17
$18.72
$26.17 avg
$39.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.10M | 766.2K | 1.76M |
| Net Income | -43,744,179 | -27,305,979 | 288.6K |
| Profit Margin | -3,959.4% | -3,761.4% | 16.4% |
| EBITDA | -47,415,078 | -31,241,728 | 503.0K |
| Free Cash Flow | — | — | 335.8K |
| Rev Growth | +44.2% | +44.2% | +14.5% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |